Chua Song Lin, Ding Yichen, Liu Yang, Cai Zhao, Zhou Jianuan, Swarup Sanjay, Drautz-Moses Daniela I, Schuster Stephan Christoph, Kjelleberg Staffan, Givskov Michael, Yang Liang
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 639798
Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University, Singapore 637551.
Open Biol. 2016 Nov;6(11). doi: 10.1098/rsob.160162.
The host immune system offers a hostile environment with antimicrobials and reactive oxygen species (ROS) that are detrimental to bacterial pathogens, forcing them to adapt and evolve for survival. However, the contribution of oxidative stress to pathogen evolution remains elusive. Using an experimental evolution strategy, we show that exposure of the opportunistic pathogen Pseudomonas aeruginosa to sub-lethal hydrogen peroxide (HO) levels over 120 generations led to the emergence of pro-biofilm rough small colony variants (RSCVs), which could be abrogated by l-glutathione antioxidants. Comparative genomic analysis of the RSCVs revealed that mutations in the wspF gene, which encodes for a repressor of WspR diguanylate cyclase (DGC), were responsible for increased intracellular cyclic-di-GMP content and production of Psl exopolysaccharide. Psl provides the first line of defence against ROS and macrophages, ensuring the survival fitness of RSCVs over wild-type P. aeruginosa Our study demonstrated that ROS is an essential driving force for the selection of pro-biofilm forming pathogenic variants. Understanding the fundamental mechanism of these genotypic and phenotypic adaptations will improve treatment strategies for combating chronic infections.
宿主免疫系统提供了一个充满对抗微生物和活性氧(ROS)的恶劣环境,这些物质对细菌病原体有害,迫使它们为生存而适应和进化。然而,氧化应激对病原体进化的贡献仍然难以捉摸。我们采用实验进化策略表明,将机会性病原体铜绿假单胞菌暴露于亚致死水平的过氧化氢(HO)中120代后,出现了促进生物膜形成的粗糙小菌落变体(RSCVs),而l-谷胱甘肽抗氧化剂可以消除这种变体。对RSCVs的比较基因组分析表明,编码WspR双鸟苷酸环化酶(DGC)抑制剂的wspF基因中的突变,导致细胞内环状二鸟苷酸含量增加和Psl胞外多糖的产生。Psl提供了对抗ROS和巨噬细胞的第一道防线,确保了RSCVs相对于野生型铜绿假单胞菌的生存适应性。我们的研究表明,ROS是选择促进生物膜形成的致病变体的重要驱动力。了解这些基因型和表型适应的基本机制将改善对抗慢性感染的治疗策略。